key: cord-0818528-6c7x2o7m
authors: Pandit, Priyanka; Bhatt, Puneet; Sahay, Rima R.; Joshi, Yash; Patil, Deepak Y.; Yadav, Pragya D.
title: A case of breakthrough infection with SARS-CoV-2 Delta derivative and reinfection with Omicron variant in a fully vaccinated health care professional
date: 2022-04-18
journal: J Infect
DOI: 10.1016/j.jinf.2022.04.023
sha: df537ce3250b49285bd446783e58603004d70c61
doc_id: 818528
cord_uid: 6c7x2o7m

nan

human IgG ELISAs namely, whole virion inactivated antigen, receptor Binding Domain of Spike Protein (S1RBD) specific IgG and Nucleocapsid (N) protein IgG capture ELISA as described earlier 7 .IgG antibody titre was found 1:400, 1:1300 and 1:80 for whole antigen, S1-RBD and N protein ELISA. Although the case had a breakthrough infection followed by a reinfection, the antibody titres were lower than expected.

With all these findings, we confirm the case of a breakthrough infection with Delta despite the hybrid immunity followed by a reinfection with Omicron post breakthrough 6 infection. A recent study has shown neutralization for Omicron variant being reduced to 25.9 fold after a previous delta infection 10 

Authors do not have a conflict of interest among themselves.

Financial support was provided by the Indian Council of Medical Research (ICMR), New

Delhi at ICMR-National Institute of Virology, Pune under intramural funding 'COVID-19'.

Evaluation of disease severity during SARS-COV-2 reinfection

Variants of Concern responsible for SARS-CoV-2 vaccine breakthrough infections from India

Reinfection or reactivation of severe acute respiratory syndrome coronavirus 2: a systematic review

Development of in vitro transcribed RNA as positive control for laboratory diagnosis of SARS-CoV-2 in India

Predominance of delta variant among COVID-19 vaccinated and unvaccinated individuals

Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity

Longitudinal clinic-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2

COVID-19 vaccines in the age of the delta variant

A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant

1.1.529 leads to widespread escape from neutralizing antibody responses

Authors gratefully acknowledge the encouragement and support extended by Prof.